SACK1H and prostate carcinoma: Moreover, higher expression of FAM83H is associated with an increased recurrence rate of prostatic cancer patients and shorter survival of uterine cancer [8], hepatocellular carcinoma [4], and clear cell renal cell carcinoma patients [11].